The Clastogenic Effect of 5-methoxypsoralen Plus UV-A in Human Lymphocytes in Vitro and Its Modification by the Anticlastogen Beta-aminoethylisothiouronium

Overview

Journal Hum Genet

Specialty Genetics

Date 1987 Jun 1

PMID 3610148

Authors

G Abel

A Mannschedel

Affiliations

Soon will be listed here.

Abstract

The treatment of human lymphocytes in vitro with 5-methoxypsoralen (5-MOP) plus UV-A induces a dose-dependent increase in the SCE rate and in structural chromosome aberrations. We carried out tests to see whether the clastogenic effect of 5-MOP plus UV-A could be reduced by the anticlastogen beta-aminoethylisothiouronium (AET). The occurrence of a protective effect proved to be dependent upon the conditions of treatment. When AET was present over a long period of time (22 h) in cultures with 5-MOP, the number of breaks was reduced compared with such cultures without AET (reduction factor 0.5-0.6). On the other hand, a short period of action by AET (1.5 h) in the presence of 5-MOP produced no reduction of breaks. Posttreatment with AET (20 h) yielded an obvious protective effect (reduction factor 0.2-0.4). The possible mechanisms of the protective effect of AET are discussed.

References

Bridges B, Mottershead R . Frameshift mutagenesis in bacteria by 8-methoxypsoralen (methoxalen) in the dark. Mutat Res. 1977; 44(3):305-12. DOI: 10.1016/0027-5107(77)90090-2. View

Schimmer O . [Comparison of photomutagenic activities of 5-mop (bergapten) and 8-mop (xanthotoxin) in chlamydomonas reinhardii (author's transl)]. Mutat Res. 1981; 89(4):283-96. DOI: 10.1016/0165-1218(81)90109-9. View

Abel G, Schimmer O . Induction of structural chromosome aberrations and sister chromatid exchanges in human lymphocytes in vitro by aristolochic acid. Hum Genet. 1983; 64(2):131-3. DOI: 10.1007/BF00327108. View

AMBRUS C, AMBRUS J, Friedman M, PICKREN J, MIRAND E, Kishel S . Protection of normal tissues with 2-aminoethylisothiouronium during local pelvic radiation in monkeys. Cancer Res. 1983; 43(6):2857-61. View

Clarke C, Wade M . Evidence that caffeine, 8-methoxypsoralen and steroidal diamines are frameshift mutagens for E. coli K-12. Mutat Res. 1975; 28(1):123-5. DOI: 10.1016/0027-5107(75)90322-x. View

Song P, Tapley Jr K . Photochemistry and photobiology of psoralens. Photochem Photobiol. 1979; 29(6):1177-97. DOI: 10.1111/j.1751-1097.1979.tb07838.x. View

Natarajan A, Ashwood-Smith M, Poulton G . Chromosomal damage induced by furocoumarins and UVA in hamster and human cells including cells from patients with ataxia telangiectasia and xeroderma pigmentosum. Mutat Res. 1981; 84(1):113-24. DOI: 10.1016/0027-5107(81)90055-5. View

Honigsmann H, Jaschke E, Gschnait F, Brenner W, Fritsch P, Wolff K . 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis. Br J Dermatol. 1979; 101(4):369-78. DOI: 10.1111/j.1365-2133.1979.tb00014.x. View

Bredberg A . Genetic toxicity of psoralen and ultraviolet radiation in human cells. Acta Derm Venereol Suppl (Stockh). 1982; 104:1-40. View

10.

Cartwright L, Walter J . Psoralen-containing sunscreen is tumorigenic in hairless mice. J Am Acad Dermatol. 1983; 8(6):830-6. DOI: 10.1016/s0190-9622(83)80012-7. View

11.

Gebhart E . The anticlastogenic effect of various combinations of cysteamine, AET, HCT, and amino acids on chromosome damage by trenimon and bleomycin in human lymphocytes in vitro. Hum Genet. 1978; 43(2):185-203. DOI: 10.1007/BF00293595. View

12.

Papadopoulo D, Averbeck D . Genotoxic effects and DNA photoadducts induced in Chinese hamster V79 cells by 5-methoxypsoralen and 8-methoxypsoralen. Mutat Res. 1985; 151(2):281-91. DOI: 10.1016/0027-5107(85)90081-8. View

13.

Gebhart E . Antimutagens. Data and problems. Humangenetik. 1974; 24(1):1-32. DOI: 10.1007/BF00281107. View

14.

Kraemer K, Weinstein G . Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light. J Invest Dermatol. 1977; 69(2):211-4. DOI: 10.1111/1523-1747.ep12506316. View

15.

Reshad H, Challoner F, POLLOCK D, Baker H . Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol. 1984; 110(3):299-305. DOI: 10.1111/j.1365-2133.1984.tb04635.x. View

16.

Abel G, Schimmer O . Effect on chromosomes by coumarin derivatives in the dark. Planta Med. 1981; 42(4):333-43. DOI: 10.1055/s-2007-971653. View

17.

Stern R, Thibodeau L, Kleinerman R, Parrish J, Fitzpatrick T . Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med. 1979; 300(15):809-13. DOI: 10.1056/NEJM197904123001501. View

18.

Veronese F, Bevilacqua R, Schiavon O, Rodighiero G . Drug-protein interaction: plasma protein binding of furocoumarins. Farmaco Sci. 1979; 34(8):716-25. View

19.

Quinto I, Averbeck D, MOUSTACCHI E, Hrisoho Z, Moron J . Frameshift mutagenicity in Salmonella typhimurium of furocoumarins in the dark. Mutat Res. 1984; 136(1):49-54. DOI: 10.1016/0165-1218(84)90133-2. View

20.

Young A, Barth J . Comparative studies on the photosensitizing potency of 5-methoxypsoralen and 8-methoxypsoralen as measured by cytolysis in Paramecium caudatum and Tetrahymena pyriformis, and growth inhibition and survival in Candida albicans. Photochem Photobiol. 1982; 35(1):83-8. DOI: 10.1111/j.1751-1097.1982.tb03814.x. View